Prevalence and Impact of Medical Comorbidity in Alzheimer's Disease
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We examined the prevalence of comorbid medical illnesses in Alzheimer's disease (AD) patients at different severity levels. We also examined the effect of cumulative medical comorbidity on cognition and function. METHODS: Analyses of data from 679 AD patients (Mini-Mental State Exam score range 0-30, mean +/- SD = 11.8 +/- 8) from 13 sites (four dementia centers assessing outpatients, four managed care organizations, two assisted living facilities, and three nursing homes) prospectively recruited using a stratification approach including dementia severity and care setting. Medical comorbidity was quantified using the Cumulative Illness Rating Scale-Geriatric. RESULTS: Across patients, 61% had three or more comorbid medical illnesses. Adjusting for age, gender, race, and care setting, medical comorbidity increased with dementia severity (mild to moderate, p <.01; moderate to severe, p <.001). Adjusting for age, educational level, gender, race, and care setting, higher medical comorbidity was associated with greater impairment in cognition (p <.001) and in self-care (p <.001). CONCLUSIONS: Despite the limitation of a cross-sectional design, our initial findings suggest that there is a strong association between medical comorbidity and cognitive status in AD. Optimal management of medical illnesses may offer potential to improve cognition in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The American Journal of Managed Care
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc · Cited by 3,237
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 1×
“We used the three summary measures (total number of endorsed categories, sum of scores across the endorsed categories, and the severity index [the total score divided by number of categories]) that have been previously validated (5,6).”
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population
Parmelee, P. A., Thuras, P. D., Katz, I. R., & Lawton, M. P. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb06377.x · Cited by 948
Multi-Attribute Health Status Classification Systems: Health Utilities Index
Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507060-00004 · Cited by 820
Stiff‐man syndrome treated with intrathecal baclofen
Penn, R. D., & Mangieri, E. A. (1993) · Neurology · doi:10.1212/wnl.43.11.2412 · Cited by 231
Symptom Patterns and Comorbidity in the Early Stages of Alzheimer's Disease
McCormick, W. C., Kukull, W. A., van Belle, G., Bowen, J. D., Teri, L., & Larson, E. B. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb04974.x · Cited by 154
Shelton, P., Sager, M. A., & Schraeder, C. (2000) · PubMed · Cited by 80
Comorbidity and Its Effect on Mortality in Nursing Home Patients with Dementia
Dijk, P. T. M. V., Dippel, D. W. J., van der Meulen, J., & Habbema, J. D. F. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199603000-00007 · Cited by 76
The pharmacoeconomics of Alzheimer's disease.
Fillit, H. M. (2000) · PubMed · Cited by 75
Vascular aspects in Alzheimer’s disease
Skoog, I. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_6 · Cited by 71 · cited 1×
“Accumulating epidemiological and neuropathological evidence supports an association between Alzheimer’s disease and several vascular risk factors, such as hypertension, coronary artery disease, diabetes mellitus, ischemic white matter lesions, and generalized atherosclerosis (10).”
Leon, J., Neumann, P. J., Hermann, R. C., Hsu, M., Cummings, J. L., Doraiswamy, P. M., & Marin, D. B. (2000) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750001500206 · Cited by 30
Self-citationvan der Cammen, T. J. M., Verschoor, C. J., van Loon, C. P. M., van Harskamp, F., de Koning, I., Schudel, W. J., Slooter, A. J. C., Broeckhoven, C. V., & van Duijn, C. M. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02749.x · Cited by 28
Combination Therapy for Early Alzheimer's Disease: What Are We Waiting for?
Doraiswamy, P. M., & Steffens, D. C. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04556.x · Cited by 20
Self-citationBlack, S. E., Patterson, C., & Feightner, J. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001219 · Cited by 14
Assessing physical status in Alzheimer disease research.
Warshaw, G. A. (1997) · PubMed · Cited by 7
Cited by
Missed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
Waldemar, G., Dubois, B., Emre, M., Georges, J., McKeith, I. G., Rossor, M., Scheltens, P., Tariska, P., & Winblad, B. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01605.x · Cited by 617
EFNS guidelines for the diagnosis and management of Alzheimer's disease
Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., Sorbi, S., Scheltens, P., & Dementia, O. B. O. T. E. S. P. O. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03040.x · Cited by 490
Comorbidity and dementia: a scoping review of the literature
Bunn, F., Burn, A.-M., Goodman, C., Rait, G., Norton, S., Robinson, L., Schoeman, J., & Brayne, C. (2014) · BMC Medicine · doi:10.1186/s12916-014-0192-4 · Cited by 451
“prevalence of comorbid medical conditions and related complaints [2-5].”
BackgroundMethodInfluentialThe Association Between Delirium and Cognitive Decline: A Review of the Empirical Literature
Jackson, J. C., Gordon, S. M., Hart, R. P., Hopkins, R. O., & Ely, E. W. (2004) · Neuropsychology Review · doi:10.1023/b:nerv.0000028080.39602.17 · Cited by 388
Metadata
- Authors
- Doraiswamy, P. M., Leon, J., Cummings, J. L., Marin, D., & Neumann, P. J.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 57
- Issue
- 3
- Pages
- M173-M177
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2158460231
- Cited by
- 269
- References
- 17
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.